During my seven years as president and CEO of Susan G. Komen, I’ve witnessed the impact of innovation in our mission to end breast cancer for good. Over the past four decades, we’ve seen a 44% reduction in breast cancer mortality, thanks to early detection and better treatments. AI is now accelerating this progress with its capacity to analyze vast datasets, discover new patterns and enhance diagnostic accuracy.
Take, for example, the groundbreaking work of Komen scholar Dr. Regina Barzilay. Using her own mammograms in her research at MIT, Dr. Barzilay demonstrated how AI could have detected her breast cancer much earlier, potentially improving her prognosis. Studies show that incorporating AI into mammogram analysis boosts cancer detection rates by 20%, without increasing false positives. This is a significant leap forward, as early detection is key to a better chance at positive outcomes and survival. Learn more
Biocon Founder, Chairman and Managing Director and Advisory Board member of MIT Jameel Clinic Kiran Mazumdar-Shaw was recognized in Forbes' 2024 list of the World's Most Powerful Women. The list recognizes 100 exceptional women in fields such as finance, technology, media and beyond, who have significant visibility and economic impact, influencing over 1 billion people around the world. Learn more